INTERNATIONAL PATENT: NANJING MEDICAL UNIVERSITY, 南京医科大学 FILES APPLICATION FOR "NEW INTEGRATED TUMOR DIAGNOSIS AND TREATMENT AGENT TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN"

GENEVA, Feb. 7 -- NANJING MEDICAL UNIVERSITY (101 Longmian Avenue, Jiangning DistrictNanjing, Jiangsu 211166), 南京医科大学 (中国江苏省南京市江宁区龙眠大道101号) filed a patent application (PCT/CN2024/124962) for "NEW INTEGRATED TUMOR DIAGNOSIS AND TREATMENT AGENT TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN" on Oct 15, 2024. With publication no. WO/2026/025641, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIP...